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ABSTRACT
Zebrafish (Danio rerio) larvae have been suggested as vertebrate model to complement or even replace mammals for rapidly
assessing behavioral effects of psychoactive drugs. Yet, divergent responses have been reported in mammals and fish
despite the conservation of many drug targets. Cocaine, eg, acts as stimulant in mammals but no such response has been
documented for zebrafish larvae. We hypothesized that differences in exposure routes (inhalation or injection in mammals
vs waterborne in fish) may be a reason for differences in behavioral responses. We characterized cocaine toxicokinetics by
liquid chromatography-mass spectrometry and found its rapid uptake into larvae. We used Matrix-assisted laser
desorption ionization-mass spectrometry imaging for the first time to characterize internal distribution of cocaine in
zebrafish larvae. Surprisingly, eyes accumulated the highest amount of cocaine and retained most of it even after 48h
depuration. We attribute this to trapping by pigment melanin, a thus far little explored mechanism that may also be
relevant for other basic drugs. Cocaine also reached the brain but with levels similar to those in trunk indicating simple
passive diffusion as means of distribution which was supported by toxicokinetic models. Although brain levels covered
those known to cause hyperactivity in mammals, only hypoactivity (decreased locomotion) was recorded in zebrafish
larvae. Our results therefore point to cocaine’s anesthetic properties as the dominant mechanism of interaction in the fish:
upon entry through the fish skin and gills, it first acts on peripheral nerves rapidly overriding any potential stimulatory
response in the brain.
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The steadily increasing number of psychoactive substances en-
tering the market, both licit and illicit, is intensifying the de-
mand to assess their safety and efficacy. Current assessment
methods rely on rodents such as mice and rats and hence re-
quire substantial cost and time investments. This limits the risk
assessment to a few substances per year. According to the
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European Drug Record 2015 (Jo~ao Goul~ao, 2015), only 6 such sub-
stances were tested in 2014; this being regarded as an unprece-
dented achievement. In contrast, over 400 illicit psychoactive
drugs entered the market since 2005—with 101 new substances
in 2014 alone. Therefore, scientists and regulators alike agree
that new approaches to behavioral testing are needed. These
should be fast and ideally less controversial in terms of animal
ethics.
One suggested alternative approach to behavioral testing in
rodents is the use of zebrafish (Danio rerio). Indeed, as a verte-
brate, zebrafish has conserved pharmacological targets and ner-
vous system structures comparable with mammals, including
humans (Howe et al., 2013; Rinkwitz et al., 2011). When
compared with rodents, zebrafish offers advantages such as
higher fecundity, faster development, and lower quantities of
test chemical required (Banote et al., 2013; Rihel and Ghosh,
2015). Especially the larval stage of zebrafish offers features at-
tractive for drug screening: the larvae can be housed in multi-
well plates, thus not only requiring little volumes for testing but
also offering the potential for medium to high-throughput
screening of diverse endpoints, including behavioral alterations
(Kokel et al., 2010; Rihel et al., 2010). On the other hand, the small
size of the larvae has thus far prevented that observed drug ef-
fects were linked to concentrations at target sites, even though
the importance of this aspect has been highlighted (Rihel and
Ghosh, 2015).
Despite the widespread advocacy for the use of zebrafish as
a general vertebrate model for behavioral studies (Best et al.,
2008; Winter et al., 2008), our understanding of the neurological
and pharmacological bases of behavior in this species remains
rather limited. Moreover, the concordance of neurobehavioral
effects of chemicals between zebrafish and mammals is rela-
tively low, especially for larval stages. For example, cocaine, a
classical drug with known stimulant properties in mammals
(Benowitz, 1993; Degenhardt and Hall, 2012), produced only
hypoactive responses in zebrafish larvae (Irons et al., 2010). The
reasons for this discrepancy are not yet understood.
Cocaine acts on monoaminergic neurotransmitter systems
(Ritz et al., 1987). Lower comparability of behavioral responses
between larval zebrafish and adult mammals may be due to the
incomplete maturation of neural circuits in the former. Another
important difference between these models may be the expo-
sure route: while in mammals cocaine and other psychoactive
drugs are usually inhaled, snorted or injected (Booze et al., 1997),
they are commonly delivered by waterborne exposure in zebra-
fish (Boehmler et al., 2007; Irons et al., 2010). This may result in
large differences in uptake and internal distribution, ie, phar-
maco- or toxicokinetic processes, which in turn may influence
the effects observed. For example, apart from its stimulatory ac-
tions in the brain, cocaine is known to also act as a local anes-
thetic by blocking voltage-gated sodium channels. This effect is
particularly relevant for peripheral nerves (Dunwiddie et al.,
1988; Ikemoto and Witkin, 2003). Thus, it can be hypothesized
that the effects elicited by cocaine may differ depending on the
internal distribution patterns and concentrations at particular
target sites.
In this study, we aimed to explore if the peculiarities of co-
caine toxicokinetics in zebrafish larvae exposed through water
may explain the discrepancy in the behavioral effects observed
in zebrafish larvae and mammals. We focused explicitly on lar-
vae because this life stage is widely used to test psychoactive
drugs. We approached our research question by simultaneously
assessing behavioral effects and toxicokinetic profiles of co-
caine. Uptake, biotransformation and elimination were studied
by liquid-chromatography-tandem mass spectrometry (LC-MS/
MS) in conjunction with toxicokinetic modeling, while drug dis-
tribution was characterized by matrix assisted laser desorption
and ionization mass spectrometry imaging (MALDI-MSI). Our
work shows that employment of different exposure routes re-
sults in significant differences in toxicokinetics, likely bearing a
significant contribution to the opposing behavioral responses to
cocaine observed in zebrafish larvae and mammals.
MATERIALS AND METHODS
Experimental Animals
Wild-type zebrafish originally obtained from OBI petshop
(Leipzig, Germany) were maintained and bred in our facility ac-
cording to the guidelines published by (Nüsslein-Volhard and
Dahm, 2002). Fish were housed in groups of 25–30 and were
reared in static containers in reconstituted water [294.0mg/l
CaCl2.2H2O, 123.2mg/l MgSO4.7H2O, 64.74mg/l NaHCO3 and
5.7mg/l KCl; ISO 15088:2007(E); 2007]. Manual water exchange
and siphoning of solid wastes was carried out once a week. Fish
were fed twice daily with a combination of live food (Artemia
nauplia) and dry flakes (Tetramin, Switzerland). The room was
maintained at 28C and 14/10 h light/dark cycle. Eggs for expo-
sure studies were obtained by group crosses and were collected
1h after the lights were turned on. They were washed and
raised in embryo medium in petri dishes of approximately 50
per dish until 5 days post-fertilization (dpf) in an incubator at
28C with the same light/dark cycle conditions as mentioned
earlier. All procedures were in accordance with the animal pro-
tection guidelines. Experiments with the larvae were approved
by the Cantonal Veterinary Office.
Uptake, Biotransformation, Distribution and Elimination
Kinetics
Uptake, Biotransformation and Elimination of Cocaine
Cocaine hydrochloride was purchased from Lipomed AG,
Switzerland. For exposures of larvae, 1mM stock solution of
cocaine was dissolved in an appropriate volume of embryo
medium to achieve the desired concentrations.
To identify the range of non-toxic to toxic concentrations of
cocaine, zebrafish larvae were exposed at 4 dpf for 24h to co-
caine at concentrations of 5, 50, and 500 mM. The larvae were
monitored on 5 dpf and the abnormalities were noted. Based on
the results obtained from this study, all further experimenta-
tion was limited up to 50 mM (Supplementary Figure S1).
Larvae of 5 dpf were exposed to 5 and 50 mM cocaine. For the
uptake analysis, 16 larvae were pooled into pre-weighed 2ml
lysing matrix tubes containing metal beads (MP Biomedicals,
France), after 0.25, 0.5, 1, 3, 6, 8, 10, 24, 27, and 31h exposure,
washed with PBS and frozen in liquid nitrogen. To study the
clearance of cocaine from larvae, they were transferred into
cocaine-free medium (reconstituted water medium) after 24h of
uptake and collected at 1, 3, 8, 24, 27, 31, and 48h of depuration
following the same procedure. Exposure medium was also col-
lected during uptake and depuration experiments at the same
time points and preserved until further analysis by freezing in
liquid nitrogen.
On the day of analysis, fish samples were defrosted first at
4C for 1h and then at room temperature for 2h. A volume of
1ml of ammonium formate buffer (5 mM, pH 3.1) was added and
samples were homogenized in Fast Prep-24 Instrument (MP
Biomedicals, France). The homogenate was spiked with internal
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standard at a concentration of 5 mM cocaine-D3 and 0.25 mM
norcocaine-D3 (cocaine metabolite) and extracted with
acetonitrile (Sigma Aldrich, Switzerland). After centrifugation
for 5min at 10 000 rpm, the supernatant was mixed with eluent
C: D (eluent C: 25 mM ammonium acetate pH 4 and eluent D:
acetonitrile with 0.1% acetic acid) at a ratio of 1:1 and was
analyzed for cocaine and its metabolites benzoylecgonine (BEC),
ecgonine methyl ester (EME) and norcocaine using LC-MS/MS.
The calibration curves were linear in the concentration ranges
of 0.05–20 mM for cocaine and 0.0025–3 mM for norcocaine. For
analysis of exposure medium samples, they were diluted 1000
times with eluent and internal standards were added at the
same concentrations as described earlier before the LC-MS/MS
analysis.
Analytes were separated on a Kinetex PFP (pentafluoro-
phenyl) liquid chromatography (LC) column (50  2.1mm,
2.6 mm) maintained at 35 C. Detection was performed by
Applied Biosystems 5500 Q Trap linear ion trap (LIT) triple quad-
rupole mass spectrometer (AB Sciex, Germany) with Analyst
software (Version 1.5.1, AB Sciex, Germany). The mobile phase
gradient was applied at a flow rate of 0.35 ml/min with eluent C
and eluent D. The gradient was programmed as follows: 0–
0.5min: 10% eluent D; 0.5–4.5min: gradient increase to 90% elu-
ent D; 4.5–5min: 90% eluent D; 5–5.010min: gradient decrease to
10% eluent D; 5.010–6min: 10% eluent D. Multiple reaction mon-
itoring (MRM) transitions were acquired for cocaine (304 ! 182),
norcocaine (290 ! 168), BEC (290 ! 168), and EME (200 ! 182).
Cocaine and norcocaine concentrations were quantified based
on the standard curves. Due to the non-enzymatic formation,
BEC and EME were also detected in the exposure medium,
therefore these 2 metabolites were not followed further in inter-
nal concentration measurements.
Distribution of Cocaine: Visualisation by MALDI MSI
This work is the first report where MALDI imaging analysis was
performed in zebrafish larvae. Distribution analysis of cocaine
in the whole body was performed after 8h of exposure by
matrix-assisted laser desorption ionization mass spectrometry
imaging (MALDI MSI). Larvae were euthanized by cold water eu-
thanasia followed by 3 washes in PBS. Individual larvae were
positioned on blocks containing Optimal Cutting Temperature
media (Thermo Scientific, USA) and frozen by placing them on
dry ice. Transverse, sagittal and coronal sections of 16 mm thick-
nesses were made with the cryotome (Microm HM 560, Thermo
Scientific, USA) and optical images were taken with the Leica
microscope (Leica Application Suite Advanced Fluorescence,
Mannheim, Germany).
MALDI matrix (2, 5 dihydroxybenzoic acid) was applied using
a robotic matrix application system (TM-sprayer, HTX
Technologies, USA). MALDI-MS images were acquired in MRM
mode with positive ionization on a Flashquant Workstation (AB
Sciex, Germany) fitted with a MALDI source consisting of a high
repetition laser (Nd:YAG, 355nm; 1000Hz). The laser had an el-
liptic shape of 200  100 lm and worked in the continuous ras-
tering oversampling mode leading to a spatial resolution of
50 mm. For image formation, the intensity of the MRM signals
was translated into a false colour scale with black representing
low and red high cocaine concentrations. Enhanced product ion
(EPI) spectra for confirmation were acquired in discrete mode
with a laser burn time of 1 s and a scan speed of 1000 amu/s ap-
plying dynamic LIT fill time. Data were acquired with Analyst
1.4.2 Software (AB Sciex). Raw data conversion from wiff files to
image files was performed with dedicated software provided by
Markus Stoeckli (Novartis, Basel) and AB Sciex. Tissue view
Software (v1.1, AB Sciex) was used for image processing.
Subsequent to mass spectrometry imaging, sections were
stained with Hematoxylin Ehrlich (TCS Biosciences, UK) and
Shandon Eosin Y (Thermo Scientific, USA) according to the pro-
cedure recommended by the supplier (Carl Roth GmbHþCo. KG,
Karlsruhe, Germany). To locate the spatial distribution of co-
caine, MALDI images were overlaid with the optical images. The
current theoretical spatial resolution of our method (50 mm)
does not allow a detailed characterization of the neuroanatomy
of the brain and eye regions showing cocaine signals. In the fu-
ture, MALDI imaging method in zebrafish larvae should be fur-
ther optimized to achieve a better spatial resolution allowing a
more precise description of internal distribution patterns.
Distribution of Cocaine: Quantification in Dissected Larval Tissues
Larval brain, eyes and trunk were dissected out as described
elsewhere (Turner et al., 2014), at 2 time points, 1 after 8h of
exposure to cocaine and another 1 following 48h of depuration
period. Briefly, larvae were anesthetized in 0.02% tricaine
(Sigma-Aldrich) and moved to a Sylgard glass petri dish. Under
zoom stereo microscope (Leica, Germany), eyes were detached
gently from the head and brains were dissected out using sharp
tungsten needles (Fine Science Tools, Germany) and forceps
(Dumont no. 5 superfine, Fine Science Tools, Germany). Brains,
eyes and trunks were pooled from 16 fish into different tubes,
snap frozen in liquid nitrogen and stored at 80C until analy-
sis. Samples were analyzed using LC-MS/MS with the method
described above for the kinetic samples analysis and quantified
against their respective matrix standard curves.
Toxicokinetic Modeling
One-Compartment Approach
One-compartment models were chosen to describe and predict
internal concentrations of cocaine in the whole zebrafish larvae
as well as to determine empirical uptake and elimination con-
stant rates for cocaine. This approach assumes that a chemical
which enters an organism is distributed instantaneously and
equally. This concept can be described by the following equa-
tion (Landrum et al., 1992; Stadnicka et al., 2012):
d
dt
Cint tð Þ ¼ kin  Cw tð Þ  kout  Cint tð Þ (1)
where Cint(t) is the internal chemical concentration (amount 
mass1), Cw(t) is the chemical concentration in the water
(amount  volume1), kin is the uptake rate constant (volume 
mass1  time1) and kout is the elimination rate constant
(time1).
Empirical uptake and elimination constant rates for cocaine
were determined by calibrating respective parameters from
equation 1 based on measured data of cocaine concentrations
in water and larvae over time, obtained in this study.
Measured internal concentrations of cocaine were compared
with predicted values obtained by using a simple 1-compart-
ment toxicokinetic model (Hendriks et al., 2001). This approach
describes the accumulation kinetics of organic chemicals as a
function of the octanol-water partition coefficient, as well as
the lipid content, weight, and trophic level of the species.
Multi-Compartment Approach
In order to account for biotransformation processes and chemi-
cal distribution in the larvae, a multi-compartment concept was
implemented. Here, internal concentration of cocaine (ie,
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where Cint_cocaine(t) is the internal concentration of cocaine
(amount mass1), Cw(t) is the cocaine concentration in the wa-
ter (amount  volume1), kin is the uptake rate constant (vol-
ume  mass1  time1), kout is the elimination rate constant
(time1) and kbiotr_met_i is the biotransformation rate to metabo-
lite i (time1).
Internal concentration of each metabolite can then be de-
scribed by the following equation:
d
dt
Cint met i tð Þ ¼ kin met i  Cw met i tð Þ þ kbiotr met i  Cint cocaine
 kout met i  Cint met i (3)
where Cint_met_i(t) is the internal concentration of metabolite i
(amount mass1), Cw_met_i(t) is the concentration of metabolite
i in the water (amount  volume1), kin_met_i is the uptake rate
constant (volume  mass1  time1), kout_met_i is the elimina-
tion rate constant (time1), kbiotr_met_i is the biotransformation
rate to metabolite i (time1) and Cint_cocaine(t) is the internal con-
centration of cocaine (amount  mass1).
In order to describe chemical distribution in the larvae, eyes
were distinguished as a separate compartment and treated in-
dependently to other larvae’s tissues in the way that different
constant rates were determined for the eyes and for the rest of
the body. The relationship between chemical concentration in
eyes and in the whole fish was determined over time by the fol-
lowing equation:
Cint larvae tð Þ ¼
Cint eyesðtÞ Weyes þ Cint restðtÞ Wrest
Weyes þWrest
(4)
where Cint_larvae(t) is the chemical concentration in the whole
larvae (amount  mass1), Cint_eyes(t) is the chemical concentra-
tion in the larvae’s eyes (amount  mass1), Cint_rest(t) is the
chemical concentration in the larvae’s tissues and organs other
than eyes (amount  mass1), Weyes is the weight of eyes (mass)
and Wrest is the weight of larvae’s tissues and organs other than
eyes (mass). Larvae’s weight is the sum of Weyes andWrest.
Model Implementation and Calibration
All models were implemented and solved using ModelMaker
(version 4.0, Cherwell Scientific Ltd., Oxford, UK) with the set-
tings described next.
1. Run
• start value: 0,
• stop value: last day of exposure,
• repeated run: no.
2. Integration
• random seed: 1,
• integration method: Runge-Kutta,
• output points: user defined (dependent on stop value)
• fixed step: no,
• accuracy: 106,
• minimum value: 1010,
• approx. no of steps: 100,




• Weighting: ordinary least squares.
• Optimization Settings:
• Convergence Change: 0.1,
• Convergence Steps: 50,
• Retry Count: 50,
• Marquardt settings:
• Initial Lambda: 100,
• Minimum Change: 1e-200,
• Fractional Change: 0.01.
Locomotor Behavior Assessment
Larvae at 5 dpf were distributed 1 larvae per well in 500 ml
volume in a 48-well plate in the morning and were returned to
the housing incubator for 3–4h for acclimatization. Locomotor
activity was recorded using the ZebraLabTM behavior tracking
system (Version 3, ViewPoint, Lyon, France) that has a camera
frame rate of 25 frames per second. The software assessed the
duration of the movements and distances traveled that were
categorized in the user interface into 3 different movements:
low speed movements (2mm/s), medium speed movements
(2–10mm/s) and high speed movements (10mm/s). Detection
threshold was set to 20 for tracking the animal excluding the
background.
After acclimatization, larvae were challenged with 5, 10, 15,
25, and 50 mM of cocaine. Locomotor activity was assessed at 3
time points; first 1 being acute exposure, where plate was
placed on the recording stage in dark immediately after adding
the drug and tracking was started after 20min of drug expo-
sure. Recording was carried out for 70min with dark and light
phases alternating each 10min. Individual larva locomotion
was quantified and assessed as distance traveled (mm) every 2
min. Second time point was after 8h exposure to cocaine; re-
cording was carried out using the same protocol as for acute
exposure. This time point was chosen because the uptake anal-
ysis showed that the plateau phase was reached around 8h of
exposure. Finally, locomotor activity was also analysed after
48h of excretion phase (for the 50 mM concentration only). This
time point was chosen because in the depuration experiment
we observed that the drug was retained by the fish eye even af-
ter 48h of depuration, allowing to address the question
whether cocaine in the eye affects locomotory behavior in
zebrafish larvae.
Statistical Analysis
All the data were exported to and analyzed using Microsoft
Excel 2010. All graphs were plotted in GraphPad PrismV
R
(Version
6 for Windows, GraphPad Software, San Diego, California, USA).
For the behavior assessment, statistical analysis was performed
using ‘RStudio’ (Version 0.98.1103, USA) by repeated measures
Analysis of Variance (ANOVA). Data were first assessed for the
significance of independent factors, ie, time, concentration and
plate with the dependent factor, ie, the locomotor activity. Data
were then segregated based on the light and dark conditions
(considering from the first light condition that followed dark pe-
riod) and ANOVA was performed with lighting conditions and
drug treatment as independent factors and the distance
traveled as the dependent factor to determine whether the con-
centration has an effect on the lighting conditions. Finally, at
each lighting condition, ANOVA was performed comparing each
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concentration to control to see if there is a significant effect;
drug treatment being independent and distance traveled being
a dependent factor followed by Bonferroni’s post-hoc
analysis (Supplementary Table S2). Statistical significance was
set at a ¼ 0.003.
RESULTS AND DISCUSSION
Cocaine is Rapidly Taken Up by Zebrafish Larvae
To test if cocaine is taken up by the zebrafish larvae from the
exposure medium and to understand the kinetics of uptake, we
exposed larvae to 5 mM (1.5mg/l) and 50 mM (15mg/l) of cocaine
and quantified it over time in both the medium and the fish
(Supplementary Table S1A). A 5 mM cocaine concentration was
previously demonstrated to be the lowest concentration caus-
ing a behavioral response (ie, hypoactivity) in zebrafish larvae
upon waterborne exposure (Irons et al., 2010). The 50 mM cocaine
concentration was used as the highest one not causing an im-
pact on zebrafish larvae survival and morphology
(Supplementary Figure S1). Cocaine was quantifiable in zebra-
fish larvae whole-body homogenates from the first time point
on (15min) and its concentration continued to increase with an
uptake rate constant, kin, of 12.9 lkg
1h1 up to about 8h, re-
sulting in cocaine internal concentrations of 81 and 445mg/kg
for the 5 and 50 mM exposures, respectively (Figure 1). The up-
take rate constant for cocaine is in a range similar to that re-
ported previously in 3–5 days post fertilization (dpf) zebrafish
for 3 synthetic pyrethroids (6.6–20.3 l kg1 h1) (Tu et al., 2014).
The pyrethroids have 3 orders of magnitude higher octanol-
water partition coefficient (logKow), suggesting a limited role of
this physico-chemical parameter in terms of chemical uptake
rates.
Being a consequence of waterborne exposure route used in
zebrafish, a continuous increase of internal cocaine concentra-
tions during several hours sharply contrasts to the uptake pro-
files common in mammals. In latter, the frequently applied
snorting, inhalation, intravenous, or subcutaneous injection
routes represent a short-term exposure and yield a fast delivery
into the blood stream, reaching mean peak plasma concentra-
tions in 5–30min (Kolbrich et al., 2006; Mendelson et al., 1998;
Perez-Reyes et al., 1994).
Cocaine is Only Slowly Eliminated from Zebrafish
Larvae
Upon transfer to clean water, zebrafish larvae eliminated about
50% of cocaine within 8h and about 63% within 24h. Thereafter,
little further elimination occurred so that after 48h of elimina-
tion, about 30% of the cocaine still remained in the fish (Figure 1
and Supplementary Table S1B). A biphasic pattern of elimina-
tion from adult zebrafish was reported for different anilines and
nitrobenzenes, with a much slower second elimination rate and
retention of 10–20% for anilines and 50% for dinitrobenzene
(Kalsch et al., 1991). The authors concluded that the 2-phase
elimination indicates processes other than passive diffusion
and speculated that a particular spatial distribution could have
led to only partial elimination. In humans, cocaine is quickly
eliminated at least from plasma (Kolbrich et al., 2006).
Zebrafish Larvae Accumulate Much More Cocaine than
Predicted Based on Whole Body Passive Diffusion
We next applied a simple 1-compartment toxicokinetic model
(Hendriks et al., 2001; Stadnicka et al., 2012), which assumes pas-
sive uptake and elimination of cocaine based on its pH-
corrected octanol-water partition coefficient (logD ¼ 1.22).
When doing so, we observed that the measured internal con-
centrations of cocaine were much higher than the predicted val-
ues (Figure 1). These results are indicative of either a sink in the
fish body and/or an active uptake mechanism. In support of the
latter, Chapy et al. (2015) demonstrated that cocaine is predomi-
nantly taken up by a proton-antiporter across the blood-brain
barrier in rodents. Elimination of cocaine from the zebrafish lar-
vae also deviated significantly from the predictions by the toxi-
cokinetic model. We therefore hypothesized that (1) cocaine
could be present at locally increased concentrations in distinct
compartments of the fish body and (2) fish retain the cocaine in
such a distinct compartment from which it cannot easily be
removed.
Cocaine Concentrates Predominantly in the Fish Eye
After an exposure to 50 mM cocaine for 8h, ie, the time needed
to reach maximum internal concentrations, coronal sections of
the larvae were prepared and analyzed by MALDI-MSI. The co-
caine signals revealed accumulation in the head region and in
FIG. 1. Uptake and elimination kinetics of cocaine in zebrafish larvae. Zebrafish larvae were exposed starting at 5 dpf for 24h and thereafter placed in cocaine-free me-
dium for up to 48h. Cocaine was quantified in whole body homogenates by LC-MS/MS. Filled dots—data from independent experimental replicates that assessed up-
take only; empty dots—data from independent experimental replicates that assessed both uptake and elimination. In red—uptake and elimination kinetics for a
starting exposure concentration of 5 mM cocaine; in blue——uptake and elimination kinetics for a starting exposure concentration of 50 mM cocaine. Solid line—fitted
1-compartment model; dashed line—prediction based on our physiologically based toxicokinetic model.
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the trunk (Figs. 2A and B). To locate the cocaine in the head re-
gion more precisely, we prepared sagittal and transverse sec-
tions. The former showed cocaine accumulation in the eyes
(Figs. 2C and D), while the latter indicated the presence of co-
caine in the forebrain (Figs. 2E and F), midbrain (Figs. 2G and H),
and hindbrain (Figs. 2I and J). The signal that was detected in
the MALDI MS was also confirmed by acquiring the correspond-
ing EPI spectrum for cocaine and comparison with the reference
spectrum (Supplementary Figure S2).
To confirm the qualitative results obtained by MALDI-MSI,
we also quantified cocaine by LC-MS/MS in dissected brain, eyes
and trunk after 8h exposure to 50 mM cocaine. Strikingly, by far
the highest concentration of cocaine was found in the eyes
(1516 6 84mg/kg), followed by the brain (406 6 44mg/kg) and
the trunk (255 6 32mg/kg) (Figure 3A). The similarity of cocaine
concentrations in the brain and the trunk suggests that a func-
tional blood-brain barrier is lacking at this stage, what is in line
with an earlier study that found an incomplete development of
the blood brain barrier in zebrafish larvae up to 9–10 dpf (Jeong
et al., 2008). Interestingly, much lower cocaine levels in the brain
were associated with cocaine intoxication leading to death in
humans (0.17–31mg/kg; Spiehler and Reed, 1985) and mice
(4mg/kg; McCarthy et al., 2004). It has to be noted though that
the majority of cocaine fatalities have been attributed to cardio-
vascular complications rather than to any neurological effects.
We also measured cocaine in the dissected brain, eyes, and
trunk after 24h exposure followed by 48h elimination. In this
scenario, the concentration of cocaine in the zebrafish eye (1331
6 98mg/kg) was still remarkably similar to that measured after
8h, while the concentrations in brain (50 6 3.7mg/kg) and trunk
(44 6 2.2mg/kg) had dropped to very low levels (Figure 3B). This
shows that cocaine not only accumulates in the fish eye to a
very high concentration but that it is also strongly retained by
this tissue.
Norcocaine, a Biotransformation Product of Cocaine,
Likewise Concentrates in the Fish Eye
To find out whether cocaine reaches the eye by internal dis-
tribution in the zebrafish larvae or via diffusion directly from
the exterior exposure medium, we analyzed the concentra-
tions of norcocaine in the dissected tissues (Figure 3C).
Norcocaine, BEC, and EME are the biotransformation products
of cocaine. The former metabolite can be produced only en-
zymatically while the latter 2 can also be formed by non-
enzymatic degradation (Supplementary Figure S3) (Jufer et al.,
1998; Warner and Norman, 2000). The distribution pattern of
norcocaine was very similar to that of cocaine. We assume
that cocaine undergoes N-demethylation to produce norco-
caine mostly in the liver, like in mammals (Brittebo, 1988;
Inaba et al., 1978; Jufer et al., 1998). Therefore, the distribution
pattern of norcocaine suggests that cocaine reached the eye
through internal distribution rather than directly from the
exterior. However, in mammals it has been shown that the
pigmented epithelium of the eye contains drug metabolising
enzyme activity (Shichi et al., 1975; Zanger and Schwab,
2013), although the expression levels particularly of CYP3A4
were very low compared with the liver (Zhang et al., 2008). In
zebrafish larvae, CYP3A65 (shared synteny with CYP3A4 in
mammals) was shown to be highly expressed in liver and in-
testine, and very low in the eye (Saad et al., 2016; Tseng
et al., 2005). Hence, we cannot completely rule out that a
very low amount of cocaine could have been taken directly
from the exposure medium through the eyes and biotrans-
formed there directly. The norcocaine concentration in the
analyzed body parts after 8h of cocaine exposure was about
0.6% compared with that of cocaine, while in the whole lar-
vae it varied from 0.5 to 3.6% at different time points which
compares well to 3% reported in humans (Jufer et al., 1998;
Kolbrich et al., 2006).
FIG. 2. Cocaine distribution in zebrafish larvae at 5 dpf exposed to 50 mM cocaine for 8h visualized by MALDI imaging. Coronal sections are depicted as Hematoxylin &
Eosin (H & E) stained optical image (A) and overlay of an optical image with the MALDI image (B), indicating cocaine distribution in the trunk and in the head region, ie,
in the brain and/or eyes, scale bar: 300 mm. Sagittal sections with optical image (C) and overlay of an optical image with the MALDI image (D) confirm the accumulation
of cocaine in the eye, scale bar: 150 mm. Transverse sections made across the head region through forebrain (H & E-stained optical image—E and overlay of an optical
image with the MALDI image—F), midbrain (H & E stained optical image—G, overlay of an optical image with the MALDI image—H) and hind brain (H & E-stained opti-
cal image—I, overlay of an optical image with the MALDI image—J) confirm the presence of cocaine in the brain, scale bar: 100 mm. Abbreviations: b, brain; e, eye; sb,
swim bladder; mp, melanophores; and t, trunk. It is important to note that the optical images of transverse sections were not superimposed with the corresponding
MALDI images but are presented next to each other. It was not achievable to overlay them due to the small size of the tissue and resolution limits of the instrument.
Untreated control fish showed no cocaine signal.
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Cocaine and Norcocaine Follow Simple Partitioning in
the Brain and Trunk but Not in the Eye
Based on the observed cocaine and norcocaine distribution, we
developed a multi-compartment toxicokinetic model to distin-
guish the eye compartment from the rest of the body (ie, brain
and trunk) and compared the measured and the predicted up-
take and elimination kinetics (Figs. 4A and B). Results demon-
strate that for both chemicals the distribution in the body
compartment without the eyes (brain and trunk) follows the as-
sumption of simple partitioning whereas in the eyes the kinet-
ics of cocaine and norcocaine is distinct.
Taken together, we conclude that, following waterborne ex-
posure, cocaine is distributed not only to the trunk and the
brain but much more so to the eyes, where it can remain for
prolonged times. In fact, accumulation of drugs in the eyes of
cats, dogs, rabbits, and mice after systemic administration has
been observed already several decades ago for diverse psycho-
pharmacological agents, such as phenothiazines and amitripty-
line and for anti-malarial drugs like chloroquine and
amopyroquine (Mason, 1977). For zebrafish larvae, high accu-
mulation of organic forms of mercury, namely methylmercury
chloride and methylmercury L-cysteineate, in the eyes, in par-
ticular the outer layer of the lens, has been reported (Korbas
et al., 2012).
One reason for the high concentration of cocaine and norco-
caine in the eyes could be their basic and lipophilic properties,
which might lead to their entrapment in melanophores due to a
high affinity to melanin (Hubbard et al., 2000; Nakahara et al.,
1995). Transfer of an electron from a donor substance to mela-
nin has been discussed to result in a trapping mechanism
strong enough to account for slow dissociation of melanin-drug
complexes (Mason et al., 1960). Interestingly, our MALDI images
suggested that in the trunk, cocaine is associated with specific
structures which resemble melanophores (Figs. 2A and B). High
affinity to melanin would also explain the slow clearance from
the eye, a phenomenon that has previously been described for
ophthalmic drugs in humans (Al-Ghananeem and Crooks, 2007)
and for intravenously injected chlorpromazine in rabbits (Potts,
1962). Future studies on the bioaccumulation of psychoactive
drugs or other chemicals in zebrafish should thus take the eye
as a potential site of local entrapment and increased concentra-
tion into account.
Having characterized the accumulation and distribution of
cocaine in zebrafish larvae, we next studied its effects on
locomotory behavior in different exposure scenarios, aiming to
understand the correlation between toxicokinetic aspects and
the behavioral alterations observed.
Zebrafish Larvae Respond to Cocaine with Hypo- but Not
Hyperactivity
We exposed larvae in 3 ways prior to analysis of locomotion:
as conventionally done for short-term exposure (20min)
(Figure 5A; see also Irons et al., 2010), after 8h of uptake (Figure
5B) and after 24h of uptake followed by 48h of elimination
(Figure 5C). Locomotion in zebrafish larvae is characterized by
higher activity in the dark compared to light. In agreement with
the results presented in Irons et al. (2010), zebrafish larvae
showed a concentration-dependent decrease in their overall lo-
comotor activity (hypo-activity) upon short-term exposure to
cocaine (Figure 5A). Hypoactivity was more severe in the dark
than in the light, with statistically significant effects observed
at concentrations of 5–10 mM and higher (Supplementary Table
S2). Zebrafish larvae exposed to cocaine concentrations below 5
mM did not show significant differences compared with control
(Supplementary Figure S4). In the larvae exposed to cocaine for
8h, a similar behavioral pattern was observed, albeit with
greater concentration-dependent differences in amplitude
(Figure 5B), likely explained by higher internal concentrations of
cocaine accumulated by this time (Figure 1). At this time point,
high concentrations of cocaine were observed in the eyes but
also in the brain and trunk (Figure 3A).
After 48h of elimination, the behavior of exposed larvae be-
came indistinguishable from that of control animals (Figure 5C).
Since at this time point high cocaine concentrations were still
observed in the eye but not in the brain or trunk, we can con-
clude that (1) observed hypoactivity is caused by cocaine accu-
mulated either in the brain or the trunk or both and (2) cocaine
accumulation in the eye does not affect locomotory behavior in
zebrafish larvae. However, cocaine was demonstrated to cause
a decrease in visual sensitivity in adult zebrafish (Darland and
Dowling, 2001). Thus, future research should investigate if other
functions associated with vision could be affected in the larvae
as well.
Possible Reasons for the Lack of Hyperactivity
In all behavioral experiments performed, only hypoactive
responses to cocaine were observed even though a wide range
FIG. 3. Concentrations of cocaine and norcocaine quantified by LC-MS/MS in dissected tissues. Zebrafish larvae at 5 dpf were exposed to 50 mM of cocaine for 8h (A, C)
or exposed to 50 mM of cocaine for 24h followed by 48h of elimination (B) before brain, eyes and trunk were dissected and analyzed for cocaine (A, B) and norcocaine
(C). Note that the y-axis scales for cocaine and norcocaine differ. Values are reported as original data (symbols; each data point was obtained from tissues pooled from
16 larvae) and mean of 3 independent experiments for uptake measurements (A, C—horizontal line) and 2 independent experiments for the elimination (B - horizontal
line). For the uptake measurements (A, C), 1-way ANOVA followed by Tukey’s multiple comparison test revealed significant difference for brain versus eyes and trunk
versus eyes (both P < .0001), while no statistical difference was seen for brain versus trunk [P¼ .0894 (A) and 0.112 (C)].
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of exposure concentrations and different exposure scenarios
were assessed. Reports on the behavioral effects of acute expo-
sure to cocaine in rodents show hyperactivity (Antoniou et al.,
1998; Badanich et al., 2008; Niculescu et al., 2005) and a dose re-
lated stimulation, with a maximal stimulation of the locomotor
activity at a dose of 59 mmol/kg (17mg/kg) (Katz et al., 1999).
Zebrafish larvae exposures resulting in comparable total body
concentrations of 6mg/kg (5 mM, 15min exposure) and about
100mg/kg (50 mM, 15min exposure) showed only hypoactivity
while lower exposure concentrations had no measurable effect
on locomotion. Moreover, as discussed above, brain tissue con-
centration in zebrafish larvae were even higher than cocaine
levels in human brain reported to be lethal. Thus, neither total
organism nor brain tissue concentrations can explain the differ-
ence in behavior. We postulate 3 reasons for the lack of hyper-
activity in zebrafish larvae. The first one refers to potential
differences in the zebrafish catecholaminergic system com-
pared to mammals. The functional homologs of the midbrain
dopaminergic system, being one of the targets of cocaine, are
not well established in zebrafish (Panula et al., 2010; Yamamoto
and Vernier, 2011). The second possible explanation is an inter-
action of cocaine with serotonin pathway. Such an interaction
has been demonstrated to lead to hypoactive response in
Caenorhabditis elegans (Ward et al., 2009). Yet, one important ob-
servation suggests to draw off attention from the brain as a sole
active target site. This observation relates to the fact that con-
centrations in the brain were similar to those in the trunk, ie, no
brain-specific cocaine accumulation occurred. Therefore we
propose that it is the local anesthetic property of cocaine that
causes the strong suppression of locomotor activity observed in
zebrafish (Butterworth and Strichartz, 1990; Dunwiddie et al.,
1988; Ikemoto and Witkin, 2003). Because the surface of the fish
larvae is quite large and because all of the cocaine first passes
through the gill and the skin as barriers, the local anesthetic ac-
tion in peripheral nerves, more specifically blockage of voltage-
gated sodium channels in muscle and gill (Chopra et al., 2007;
Dunwiddie et al., 1988; Ikemoto and Witkin, 2003), becomes
dominant even before cocaine can act in the brain.
To conclude, in search for the cause of the differences in lo-
comotory response to cocaine in zebrafish larvae and mam-
mals, we demonstrate the importance of taking toxicokinetic
processes into account. We show that, while waterborne expo-
sure does not restrain the uptake of cocaine by the organism,
the kinetics of uptake is very different from that established via
snorting, inhalation or injection routes in mammals. High inter-
nal concentrations accumulated by zebrafish larvae suggest its
overall lower sensitivity to cocaine intoxication compared to
mammals. Cocaine concentrations in brain and trunk were sim-
ilar to each other, indicating a lack of functional blood-brain
barrier at this stage. Surprisingly, the largest accumulation of
cocaine was found in the zebrafish eye, which we demonstrate
for the first time by combining LC-MS/MS analysis and MALDI
imaging. Entrapment and slow elimination of cocaine could be
a feature of melanin-drug complexes, which has been suggested
decades ago. An existence of specific retention sites within the
organism was also suggested by our toxicokinetic modeling.
This raises the question of the role of melanin in the accumula-
tion and slow elimination of drugs and other chemicals in
FIG. 4. Uptake and elimination kinetics modeling when eyes and rest of the body (ie, brain and trunk) are treated as 2 separate compartments. Zebrafish larvae were
exposed to 50 mM cocaine for 24h starting at 5 dpf and thereafter placed in cocaine-free medium for up to 48h. Cocaine (A) and norcocaine (B) were quantified by LC-
MS/MS in whole body homogenates and in dissected brain, eyes and trunk. In blue—uptake and elimination kinetics for whole larvae; in red—fitted multi-compart-
ment model for brain and trunk together; in black—fitted multi-compartment model for the eyes. Multi-compartment model fit shows that distribution in the brain
and trunk follows model predictions based on simple partitioning while distribution in the eyes is distinct.
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zebrafish larvae in general. Finally, because of the fast and sig-
nificant uptake of cocaine, the fish solely respond with hypo-
but never with hyperactivity. We propose that the permeation
of the cocaine through the fish surface upon the waterborne ex-
posure leads to anesthetic interactions with peripheral nerves
and overrides any potential hyperactive response that could be
evoked from interaction with stimulatory targets in the brain.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci.
oxfordjournals.org/.
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FIG. 5. Locomotor activity of zebrafish larvae treated with cocaine. At 5 dpf larvae were exposed to different concentrations of cocaine for 20min (A), 8 h (B), or 24h
followed by 48h of depuration (C). Distance traveled by the fish was analyzed every 2min for 70min with dark (black bars) and light phases alternating every 10min.
Data were assessed using repeated measures ANOVA. Data segregated and analyzed for the effect of concentration at different lighting conditions revealed significant
effect of cocaine on the locomotory activity after 20min of exposure (A) in both light (P ¼ 6.34e-07) and dark phases (P ¼ 3.25e-12) and after 8h of exposure (B) in both
light (P  2e-16) and dark phases (P  2e-16). Locomotor activity measured after 24h of exposure followed by transfer into clean water for 48h (C) shows no significant
effect. Values are reported as mean 6 SEM from 3 independent experiments ie, 3 plates (n¼8 larvae/concentration/plate).
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